BioMarin (BMRN) Stock Soars, Taking IBB With It

BioMarin (BMRN) stock is soaring on Thursday after promising Phase 2 trial data on a dwarfism drug, vosoritide. The IBB ETF is rallying, too. More 

Trade of the Day: IBB is Your Best Bet in Biotech

iShares NASDAQ Biotechnology Index (ETF) looks ready to break out. More 

IBB: Are Biotech Stocks Readying a Final Summertime Hurrah?

Biotech stocks have had an unprecedented run in recent years, and while a mean-reversion move is in the cards, traders can still ride the IBB ETF higher. More 

Can Biotech Stocks Break Out, Or Will They Break Down?

Biotech stocks are a step up from lottery tickets: Fortunes made and lost on the clinical results and regulatory approval. Will they break down or break out? More 

Biotech Stocks Set to Soar, So Buy This Top Biotech ETF

Biotech stocks are NOT in a bubble, and the XBI biotech ETF is a cheap and diversified way to play the long-term potential of biotechnology. More 

IBB: Bears Hold the Upper Hand in Biotechs

An ominous double top pattern has descended on biotech stocks. Profit from its continued influence on the IBB ETF with this option spread. More 

3 Biotech Stocks to Sell Now

A bear raid has descended on biotech stocks. Here's how to capitalize on continued pain in BIIB, CELG and ALXN. More